Transient perfusion and radiosensitizing effect after nicotinamide, carbogen, and perflubron emulsion administration.
In order to improve the effect of radiation on tumour response, nicotinamide, perflubron emulsion and carbogen were administered which act on both diffusion limited hypoxia and intermittent perfusion limited hypoxia. These treatments were used in different combinations. The maximal radiosensitizing effect was found with the combination of the three treatments. The aim of this study was to use a double staining method (Hoechst 33342 and DiOC7(3) to evaluate the influence of nicotinamide, perflubron emulsion and carbogen on transient perfusion in three tumour cell lines transplanted onto nude mice: one rodent (EMT6), two human (HRT18, a rectal adenocarcinoma; and Na11+, a melanoma). For untreated groups, the percentage of closed and mismatched vessels depended on the tumour cell line. Carbogen alone or carbogen plus perflubron emulsion decreased the number of mismatched and closed vessels only for the two human cell lines. Nicotinamide was effective in decreasing the percentage of mismatched and closed vessels only for the melanoma cell line. The combination of nicotinamide, carbogen and perflubron emulsion was the most effective at decreasing both percentage of mismatched and closed vessels in all three tumours studies. This combination was also the most effective at enhancing the radiation response in all three tumours.
Thomas
C D
CD
Laboratoire de Radiobiologie Cellulaire, Institut Gustave Roussy, Villejuif, France.
Stern
S
S
Chaplin
D J
DJ
Guichard
M
M
D000230:Adenocarcinoma / Q000098:blood supply / Q000473:pathology / Q000532:radiotherapy*; D000818:Animals; D002245:Carbon Dioxide / Q000008:administration & dosage / Q000494:pharmacology*; D004655:Emulsions / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D005466:Fluorocarbons / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D006842:Hydrocarbons, Brominated; D008545:Melanoma / Q000098:blood supply / Q000473:pathology / Q000532:radiotherapy*; D051379:Mice; D008819:Mice, Nude; D008856:Microscopy, Fluorescence; D009368:Neoplasm Transplantation; D009536:Niacinamide / Q000008:administration & dosage / Q000494:pharmacology*; D010100:Oxygen / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D010477:Perfusion; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage / Q000494:pharmacology*; D012004:Rectal Neoplasms / Q000532:radiotherapy; D012039:Regional Blood Flow / Q000187:drug effects; D012680:Sensitivity and Specificity; D014407:Tumor Cells, Cultured
D004655:Emulsions; D005466:Fluorocarbons; D006842:Hydrocarbons, Brominated; D011838:Radiation-Sensitizing Agents; D002245:Carbon Dioxide; D009536:Niacinamide; C011700:carbogen; C003072:perflubron; D010100:Oxygen